For some Precision Biosciences executives and investors, optimism is in the air.
Precision (Nasdaq: DTIL) made its debut on the Nasdaq stock exchange, trading 9 percent over the initial offering price of $16 on the first day of trading.
On Friday afternoon, the company's stock hovered around $17.55 a share, slightly up from the day before.
That’s good news for some of its executives and major stockholders, who are hoping for a northbound journey of the stock in the coming weeks.
